5-HT2B Receptor on Macrophages: What for?
暂无分享,去创建一个
Á. Corbí | C. Nieto | Ignacio Rayo | I. Rayo | Concha Nieto
[1] S. Landreville,et al. Analysis of the proteasome activity and the turnover of the serotonin receptor 2B (HTR2B) in human uveal melanoma. , 2019, Experimental eye research.
[2] M. Mesnil,et al. Serotonin and human cancer: A critical view. , 2019, Biochimie.
[3] M. Kimura,et al. Effect of Selective Serotonin (5-HT)2B Receptor Agonist BW723C86 on Epidermal Growth Factor/Transforming Growth Factor-α Receptor Tyrosine Kinase and Ribosomal p70 S6 Kinase Activities in Primary Cultures of Adult Rat Hepatocytes. , 2019, Biological & pharmaceutical bulletin.
[4] R. Kukreti,et al. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk , 2019, International journal of molecular sciences.
[5] J. Launay,et al. Enhanced Renewal of Erythroid Progenitors in Myelodysplastic Anemia by Peripheral Serotonin. , 2019, Cell reports.
[6] Fred H. Gage,et al. Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3 , 2019, Nature.
[7] V. Gerriets,et al. Beyond a neurotransmitter: The role of serotonin in inflammation and immunity. , 2019, Pharmacological research.
[8] O. Hermine,et al. Serotonin, hematopoiesis and stem cells , 2019, Pharmacological research.
[9] N. Ramoz,et al. A positive association between a polymorphism in the HTR2B gene and cocaine-crack in a French Afro-Caribbean population , 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[10] A. Dávalos,et al. Olive Oil, Palm Oil, and Hybrid Palm Oil Distinctly Modulate Liver Transcriptome and Induce NAFLD in Mice Fed a High-Fat Diet , 2018, International journal of molecular sciences.
[11] S. Guérin,et al. Transcription of the Human 5-Hydroxytryptamine Receptor 2B (HTR2B) Gene Is under the Regulatory Influence of the Transcription Factors NFI and RUNX1 in Human Uveal Melanoma , 2018, International journal of molecular sciences.
[12] L. Maroteaux,et al. Regulation of raphe serotonin neurons by serotonin 1A and 2B receptors , 2018, Neuropsychopharmacology.
[13] Hongyu Zhao,et al. Translational studies support a role for serotonin 2B receptor (HTR2B) gene in aggression-related cannabis response , 2018, Molecular Psychiatry.
[14] N. Nichols,et al. Systemic inflammation inhibits serotonin receptor 2-induced phrenic motor facilitation upstream from BDNF/TrkB signaling. , 2018, Journal of neurophysiology.
[15] W. Alrefai,et al. Serotonin is an endogenous regulator of intestinal CYP1A1 via AhR , 2018, Scientific Reports.
[16] M. Mameli,et al. Positive regulation of raphe serotonin neurons by serotonin 2B receptors , 2018, Neuropsychopharmacology.
[17] G. Westergren-Thorsson,et al. Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro – a potential pathway affecting proliferation , 2018, Scientific Reports.
[18] Qingbo Xu,et al. Inhibition of 5‐Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β‐Arrestin2–Mammalian Target of Rapamycin/p70S6K Pathway , 2018, Journal of the American Heart Association.
[19] S. Djurovic,et al. Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells , 2018, Scientific Reports.
[20] E. Bullmore,et al. Effects of anti‐inflammatory drugs on the expression of tryptophan‐metabolism genes by human macrophages , 2018, Journal of leukocyte biology.
[21] L. Joosten,et al. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity , 2018, Cell.
[22] Irah L. King,et al. BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis , 2018, Cell.
[23] Shun-Fa Yang,et al. Praeruptorin A Inhibits Human Cervical Cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling , 2017, International journal of molecular sciences.
[24] Á. Corbí,et al. Serotonin drives the acquisition of a profibrotic and anti-inflammatory gene profile through the 5-HT7R-PKA signaling axis , 2017, Scientific Reports.
[25] P. Robledo,et al. Serotonin 2B Receptors in Mesoaccumbens Dopamine Pathway Regulate Cocaine Responses , 2017, The Journal of Neuroscience.
[26] N. Morrell,et al. Role of the Aryl Hydrocarbon Receptor in Sugen 5416‐induced Experimental Pulmonary Hypertension , 2017, American journal of respiratory cell and molecular biology.
[27] L. Monassier,et al. The role of 5‐HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors , 2017, British journal of pharmacology.
[28] C. Bode,et al. The Effects of Serotonin in Immune Cells , 2017, Front. Cardiovasc. Med..
[29] K. Bryniarski,et al. The role of macrophages in anti-inflammatory activity of antidepressant drugs. , 2017, Immunobiology.
[30] G. Mawe,et al. Non-conventional features of peripheral serotonin signalling — the gut and beyond , 2017, Nature Reviews Gastroenterology &Hepatology.
[31] K. Messlinger,et al. Putative role of 5-HT2B receptors in migraine pathophysiology , 2017, Cephalalgia : an international journal of headache.
[32] P. Olmos,et al. Prolonged Activation of the Htr2b Serotonin Receptor Impairs Glucose Stimulated Insulin Secretion and Mitochondrial Function in MIN6 Cells , 2017, PloS one.
[33] Á. Corbí,et al. MAFB Determines Human Macrophage Anti-Inflammatory Polarization: Relevance for the Pathogenic Mechanisms Operating in Multicentric Carpotarsal Osteolysis , 2017, The Journal of Immunology.
[34] K. Tung,et al. Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation , 2016, Nature.
[35] A. Dean,et al. Metformin Reverses Development of Pulmonary Hypertension via Aromatase Inhibition , 2016, Hypertension.
[36] G. Westergren-Thorsson,et al. 5‐HT 2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo , 2016, Physiological reports.
[37] D. Feuerbach,et al. Antidepressant therapies inhibit inflammation and microglial M1-polarization. , 2016, Pharmacology & therapeutics.
[38] S. Mulero-Navarro,et al. New Trends in Aryl Hydrocarbon Receptor Biology , 2016, Front. Cell Dev. Biol..
[39] R. Xavier,et al. Trained immunity: A program of innate immune memory in health and disease , 2016, Science.
[40] M. Kimura,et al. Serotonin 5-HT2B Receptor-Stimulated DNA Synthesis and Proliferation Are Mediated by Autocrine Secretion of Transforming Growth Factor-α in Primary Cultures of Adult Rat Hepatocytes. , 2016, Biological & pharmaceutical bulletin.
[41] J. Callebert,et al. Serotonin Is Involved in Autoimmune Arthritis through Th17 Immunity and Bone Resorption. , 2016, The American journal of pathology.
[42] T. Wynn,et al. Macrophages in Tissue Repair, Regeneration, and Fibrosis. , 2016, Immunity.
[43] Joshua D. Hutcheson,et al. Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension , 2016, PloS one.
[44] J. Schultze. Reprogramming of macrophages--new opportunities for therapeutic targeting. , 2016, Current opinion in pharmacology.
[45] L. Maroteaux,et al. Mice lacking the serotonin 5-HT2B receptor as an animal model of resistance to selective serotonin reuptake inhibitors antidepressants , 2016, European Neuropsychopharmacology.
[46] P. Wong,et al. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis , 2016, Acta Neuropathologica.
[47] F. Ginhoux,et al. New insights into the multidimensional concept of macrophage ontogeny, activation and function , 2015, Nature Immunology.
[48] D. Brites,et al. Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation , 2015, Front. Cell. Neurosci..
[49] R. Yirmiya,et al. Depression as a Microglial Disease , 2015, Trends in Neurosciences.
[50] E. Ponimaskin,et al. The serotonin receptor 5-HT7R regulates the morphology and migratory properties of dendritic cells , 2015, Journal of Cell Science.
[51] Terrell Holloway,et al. Epigenetic Mechanisms of Serotonin Signaling. , 2015, ACS chemical neuroscience.
[52] Kyle A. Lyman,et al. HTR7 Mediates Serotonergic Acute and Chronic Itch , 2015, Neuron.
[53] L. Maroteaux,et al. Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype , 2015, Neuropsychopharmacology.
[54] T. Irinopoulou,et al. Serotonin Modulates Developmental Microglia via 5-HT2B Receptors: Potential Implication during Synaptic Refinement of Retinogeniculate Projections. , 2015, ACS chemical neuroscience.
[55] Brian Ruffell,et al. Macrophages and therapeutic resistance in cancer. , 2015, Cancer cell.
[56] U. Bültmann,et al. The prospective association between obesity and major depression in the general population: does single or recurrent episode matter? , 2015, BMC Public Health.
[57] Robert S. Young,et al. Divergent transcriptional activation by glucocorticoids in mouse and human macrophages , 2015, The Lancet.
[58] D. Hume,et al. A transcriptional perspective on human macrophage biology. , 2015, Seminars in immunology.
[59] M. Kondo,et al. Therapeutic action of 5‐HT3 receptor antagonists targeting peritoneal macrophages in post‐operative ileus , 2015, British journal of pharmacology.
[60] Fandi Meng,et al. Serotonin Deficiency Exacerbates Acetaminophen-Induced Liver Toxicity In Mice , 2015, Scientific Reports.
[61] Norbert Weissmann,et al. 5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure , 2015, BioMed research international.
[62] Xi-Ping Huang,et al. Molecular interactions between general anesthetics and the 5HT2B receptor , 2015, Journal of biomolecular structure & dynamics.
[63] W. Khan,et al. 5-HT7 receptor signaling: improved therapeutic strategy in gut disorders , 2014, Front. Behav. Neurosci..
[64] Jie-yu Ye,et al. Serotonin Enhances Megakaryopoiesis and Proplatelet Formation via p‐Erk1/2 and F‐Actin Reorganization , 2014, Stem cells.
[65] E. Ponimaskin,et al. Serotonin 5-HT7 Receptor Is Critically Involved in Acute and Chronic Inflammation of the Gastrointestinal Tract , 2014, Inflammatory bowel diseases.
[66] S. Goerdt,et al. Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.
[67] G. Randolph,et al. Origin and functions of tissue macrophages. , 2014, Immunity.
[68] F. Ginhoux,et al. Monocytes and macrophages: developmental pathways and tissue homeostasis , 2014, Nature Reviews Immunology.
[69] Jens Titze,et al. Macrophages in homeostatic immune function , 2014, Front. Physiol..
[70] Jorge Joven,et al. CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile , 2014, The Journal of Immunology.
[71] C. Bode,et al. Acute Fluoxetine Treatment Induces Slow Rolling of Leukocytes on Endothelium in Mice , 2014, PloS one.
[72] C. Nichols,et al. Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo , 2013, PloS one.
[73] J. Launay,et al. Serotonin 2B Receptor (5-HT2B R) Signals through Prostacyclin and PPAR-ß/δ in Osteoblasts , 2013, PloS one.
[74] G. R. van den Brink,et al. Selective inhibition of mucosal serotonin as treatment for IBD? , 2013, Gut.
[75] F. Oakley,et al. Serotonin paracrine signaling in tissue fibrosis☆☆☆ , 2013, Biochimica et biophysica acta.
[76] I. Modlin,et al. Serotonin and the 5‐HT7 receptor: The link between hepatocytes, IGF‐1 and small intestinal neuroendocrine tumors , 2013, Cancer science.
[77] W. Khan,et al. Targeted Inhibition of Serotonin Type 7 (5-HT7) Receptor Function Modulates Immune Responses and Reduces the Severity of Intestinal Inflammation , 2013, The Journal of Immunology.
[78] J. Pollard,et al. Macrophage biology in development, homeostasis and disease , 2013, Nature.
[79] A. Dopazo,et al. Aryl hydrocarbon receptor contributes to the MEK/ERK-dependent maintenance of the immature state of human dendritic cells. , 2013, Blood.
[80] Steffen Jung,et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. , 2013, Immunity.
[81] Á. Corbí,et al. Serotonin Skews Human Macrophage Polarization through HTR2B and HTR7 , 2013, The Journal of Immunology.
[82] B. Kang,et al. Regulation of Serotonin-Induced Trafficking and Migration of Eosinophils , 2013, PloS one.
[83] A. Sica,et al. Macrophage plasticity and polarization in tissue repair and remodelling , 2013, The Journal of pathology.
[84] M. Prinz,et al. Microglia as modulators of cognition and neuropsychiatric disorders , 2013, Glia.
[85] S. Wood,et al. Serotonin: from top to bottom , 2012, Biogerontology.
[86] C. Hellerbrand,et al. Expression of Serotonin Receptors in Human Hepatocellular Cancer , 2012, Clinical Cancer Research.
[87] R. P. Thompson,et al. Serotonin Potentiates Transforming Growth Factor-beta3 Induced Biomechanical Remodeling in Avian Embryonic Atrioventricular Valves , 2012, PloS one.
[88] J. Hamilton,et al. Defining GM-CSF– and Macrophage-CSF–Dependent Macrophage Responses by In Vitro Models , 2012, The Journal of Immunology.
[89] J. Truchetto,et al. Antinociceptive effect of peripheral serotonin 5-HT2B receptor activation on neuropathic pain , 2012, PAIN.
[90] Alberto Mantovani,et al. Orchestration of metabolism by macrophages. , 2012, Cell metabolism.
[91] M. Lesurtel,et al. Serotonin: a double-edged sword for the liver? , 2012, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[92] David A. Hume,et al. Pig Bone Marrow-Derived Macrophages Resemble Human Macrophages in Their Response to Bacterial Lipopolysaccharide , 2012, The Journal of Immunology.
[93] R. Krishnadas,et al. Depression: an inflammatory illness? , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[94] V. Matyash,et al. Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity , 2012, Brain, Behavior, and Immunity.
[95] Alberto Mantovani,et al. Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.
[96] Xuepeng Wang,et al. Fluoxetine Promotes Remission in Acute Experimental Autoimmune Encephalomyelitis in Rats , 2012, Neuroimmunomodulation.
[97] L. Coussens,et al. Differential macrophage programming in the tumor microenvironment. , 2012, Trends in immunology.
[98] M. Humbert,et al. Serotonin 5-HT2B receptors are required for bone-marrow contribution to pulmonary arterial hypertension. , 2012, Blood.
[99] L. Maroteaux,et al. 5-HT2B receptors are required for serotonin-selective antidepressant actions , 2012, Molecular Psychiatry.
[100] James C. Cronk,et al. Wild type microglia arrest pathology in a mouse model of Rett syndrome , 2012, Nature.
[101] M. Ebrahimkhani,et al. Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease , 2011, Nature Medicine.
[102] D. Zopf,et al. C-122, a novel antagonist of serotonin receptor 5-HT2B, prevents monocrotaline-induced pulmonary arterial hypertension in rats. , 2011, European journal of pharmacology.
[103] G. Natoli,et al. Transcriptional regulation of macrophage polarization: enabling diversity with identity , 2011, Nature Reviews Immunology.
[104] J. Pollard,et al. Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory Deficits , 2011, PloS one.
[105] Carey N Lumeng,et al. Inflammatory links between obesity and metabolic disease. , 2011, The Journal of clinical investigation.
[106] A. Puig-Kröger,et al. Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. , 2011, Blood.
[107] N. Alenina,et al. Platelet-derived serotonin links vascular disease and tissue fibrosis , 2011, The Journal of experimental medicine.
[108] G. Ahern. 5-HT and the immune system. , 2011, Current opinion in pharmacology.
[109] W. Jochum,et al. Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway , 2011, Proceedings of the National Academy of Sciences.
[110] M. Lesurtel,et al. Activation of serotonin receptor‐2B rescues small‐for‐size liver graft failure in mice , 2011, Hepatology.
[111] J. Suvisaari,et al. A POPULATION-SPECIFIC HTR2B STOP CODON PREDISPOSES TO SEVERE IMPULSIVITY , 2010, Nature.
[112] M. Kaminishi,et al. Neuronal stimulation with 5-hydroxytryptamine 4 receptor induces anti-inflammatory actions via α7nACh receptors on muscularis macrophages associated with postoperative ileus , 2010, Gut.
[113] Abraham Weizman,et al. The Immunomodulatory Effect of the Antidepressant Sertraline in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis , 2010, Neuroimmunomodulation.
[114] W. Seeger,et al. Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats , 2010, European Respiratory Journal.
[115] A. Mantovani,et al. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.
[116] B. Byrne,et al. PRX-08066, a Novel 5-Hydroxytryptamine Receptor 2B Antagonist, Reduces Monocrotaline-Induced Pulmonary Arterial Hypertension and Right Ventricular Hypertrophy in Rats , 2010, Journal of Pharmacology and Experimental Therapeutics.
[117] P. Cuijpers,et al. Depression and obesity: A meta-analysis of community-based studies , 2010, Psychiatry Research.
[118] L. Tecott,et al. Serotonin Regulates Pancreatic β-Cell Mass during Pregnancy , 2010, Nature Medicine.
[119] J. Launay,et al. Serotonergic 5-HT2B Receptor Controls Tissue-nonspecific Alkaline Phosphatase Activity in Osteoblasts via Eicosanoids and Phosphatidylinositol-specific Phospholipase C* , 2010, The Journal of Biological Chemistry.
[120] I. Modlin,et al. The 5‐HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment , 2010, Cancer.
[121] Petr Tvrdik,et al. Hematopoietic Origin of Pathological Grooming in Hoxb8 Mutant Mice , 2010, Cell.
[122] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[123] L. Tecott,et al. Serotonin activates murine alveolar macrophages through 5-HT2C receptors. , 2010, American journal of physiology. Lung cellular and molecular physiology.
[124] Baoman Li,et al. 5-HT2B receptors are expressed on astrocytes from brain and in culture and are a chronic target for all five conventional 'serotonin-specific reuptake inhibitors'. , 2010, Neuron glia biology.
[125] G. Farrugia,et al. Lack of serotonin 5‐HT2B receptor alters proliferation and network volume of interstitial cells of Cajal in vivo , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[126] M. Číž,et al. Serotonin and its 5-HT(2) receptor agonist DOI hydrochloride inhibit the oxidative burst in total leukocytes but not in isolated neutrophils. , 2010, Life sciences.
[127] M. E. Hernández,et al. Evaluation of the effect of selective serotonin-reuptake inhibitors on lymphocyte subsets in patients with a major depressive disorder , 2010, European Neuropsychopharmacology.
[128] A. Buckley,et al. Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival , 2009, Breast Cancer Research.
[129] J. Mallet,et al. Serotonin has a key role in pathogenesis of experimental colitis. , 2009, Gastroenterology.
[130] N. Rosenthal,et al. A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair , 2009, Proceedings of the National Academy of Sciences.
[131] Y. Fujii‐Kuriyama,et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses , 2009, The Journal of experimental medicine.
[132] F. Di Virgilio,et al. 5-Hydroxytryptamine Modulates Migration, Cytokine and Chemokine Release and T-Cell Priming Capacity of Dendritic Cells In Vitro and In Vivo , 2009, PLoS ONE.
[133] P. Kastner,et al. MafB Restricts M-CSF-Dependent Myeloid Commitment Divisions of Hematopoietic Stem Cells , 2009, Cell.
[134] D. Wagner,et al. Serotonin stimulates platelet receptor shedding by tumor necrosis factor‐alpha‐converting enzyme (ADAM17) , 2009, Journal of thrombosis and haemostasis : JTH.
[135] H. Hartung,et al. The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. , 2009, The international journal of neuropsychopharmacology.
[136] Charles L. Raison,et al. Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.
[137] I. Sora,et al. Depletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylation. , 2009, Neoplasia.
[138] B. Roth,et al. The expanded biology of serotonin. , 2009, Annual review of medicine.
[139] J. Edwards,et al. Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.
[140] V. Setola,et al. Serotonin and Angiotensin Receptors in Cardiac Fibroblasts Coregulate Adrenergic-Dependent Cardiac Hypertrophy , 2008, Circulation research.
[141] M. Zerfaoui,et al. Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-α-Induced Inflammation with Extraordinary Potency , 2008, Journal of Pharmacology and Experimental Therapeutics.
[142] D. Gilroy,et al. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP , 2008, Blood.
[143] Baoman Li,et al. Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation , 2008, Psychopharmacology.
[144] W. Jochum,et al. Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts. , 2008, Cancer research.
[145] Kevin G. Lynch,et al. Selective Serotonin Reuptake Inhibitor and Substance P Antagonist Enhancement of Natural Killer Cell Innate Immunity in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome , 2008, Biological Psychiatry.
[146] B. Fiebich,et al. Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells , 2008, Rheumatology International.
[147] M. Lesurtel,et al. Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives , 2008, Cellular and Molecular Life Sciences.
[148] E. Bissonnette,et al. Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2 , 2007, Clinical and experimental immunology.
[149] N. Katoh,et al. Serotonin activates human monocytes and prevents apoptosis. , 2007, The Journal of investigative dermatology.
[150] R. Dantzer,et al. TNFα-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I , 2007, Journal of Neuroimmunology.
[151] B. Vargaftig,et al. Interference of methysergide, a specific 5‐hydroxytryptamine receptor antagonist, with airway chronic allergic inflammation and remodelling in a murine model of asthma , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[152] P. O’Connell,et al. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. , 2007, Blood.
[153] Soo Young Lee,et al. MafB negatively regulates RANKL-mediated osteoclast differentiation. , 2007, Blood.
[154] J. Changeux,et al. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective , 2007, Journal of leukocyte biology.
[155] T. Papadopoulos,et al. IL‐10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A–induced liver injury in mice , 2007, Hepatology.
[156] A. Antonini,et al. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. , 2007, The New England journal of medicine.
[157] B. Roth. Drugs and valvular heart disease. , 2007, The New England journal of medicine.
[158] W. Haverkamp,et al. Dopamine agonists and the risk of cardiac-valve regurgitation. , 2007, The New England journal of medicine.
[159] A. Saltiel,et al. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.
[160] M. Číž,et al. Serotonin modulates the oxidative burst of human phagocytes via various mechanisms , 2007, Platelets.
[161] M. Toth,et al. 5-Hydroxytryptamine Induces Mast Cell Adhesion and Migration1 , 2006, The Journal of Immunology.
[162] R. Tamagawa‐Mineoka,et al. Effect of serotonin on the differentiation of human monocytes into dendritic cells , 2006, Clinical and experimental immunology.
[163] L. Maroteaux,et al. Endogenous 5-HT2B receptor activation regulates neonatal respiratory activity in vitro. , 2006, Journal of neurobiology.
[164] S. Pingle,et al. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. , 2006, Blood.
[165] M. Longaker,et al. Expression of a novel gene, MafB, in Dupuytren's disease. , 2006, The Journal of hand surgery.
[166] H. Steinbusch,et al. Th1, Th2, and Th3 cytokine alterations in major depression. , 2005, Journal of affective disorders.
[167] A. Sica,et al. Macrophage polarization comes of age. , 2005, Immunity.
[168] Bryan L Roth,et al. Molecular Determinants for the Interaction of the Valvulopathic Anorexigen Norfenfluramine with the 5-HT2B Receptor , 2005, Molecular Pharmacology.
[169] K. Dev,et al. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells , 2005, Neuropharmacology.
[170] F. Di Virgilio,et al. 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. , 2005, International immunology.
[171] M. Maes,et al. Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor α and interleukin-6 , 2005, Psychiatry Research.
[172] Robert Dantzer,et al. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. , 2004, European journal of pharmacology.
[173] S. Boehme,et al. Cutting Edge: Serotonin Is a Chemotactic Factor for Eosinophils and Functions Additively with Eotaxin1 , 2004, The Journal of Immunology.
[174] L. Monassier,et al. Involvement of the Serotonin 5-HT2B Receptor in Cardiac Hypertrophy Linked to Sympathetic Stimulation: Control of Interleukin-6, Interleukin-1&bgr;, and Tumor Necrosis Factor-&agr; Cytokine Production by Ventricular Fibroblasts , 2004, Circulation.
[175] M. Humbert,et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[176] E. Candelario-Jalil,et al. Antiinflammatory effects of 5‐HT3 receptor antagonists in lipopolysaccharide‐stimulated primary human monocytes , 2004, Scandinavian journal of rheumatology. Supplement.
[177] F. Di Virgilio,et al. The Serotoninergic Receptors of Human Dendritic Cells: Identification and Coupling to Cytokine Release 1 , 2004, The Journal of Immunology.
[178] P. Albert,et al. 5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-κB to the nucleus , 2004, Brain, Behavior, and Immunity.
[179] J. Sheridan,et al. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. , 2003, Archives of general psychiatry.
[180] L. Monassier,et al. Overexpression of the Serotonin 5-HT2B Receptor in Heart Leads to Abnormal Mitochondrial Function and Cardiac Hypertrophy , 2003, Circulation.
[181] R. Gallego,et al. Serotonin upregulates the activity of phagocytosis through 5‐HT1A receptors , 2003, British journal of pharmacology.
[182] J. Cavaillon,et al. Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. , 2003, International immunology.
[183] R. Levy,et al. Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells. , 2002, The American journal of pathology.
[184] G. Kenis,et al. Effects of antidepressants on the production of cytokines. , 2002, The international journal of neuropsychopharmacology.
[185] P. Allavena,et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.
[186] M. Humbert,et al. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension , 2002, Nature Medicine.
[187] L. Maroteaux,et al. A novel role for serotonin in heart. , 2001, Trends in cardiovascular medicine.
[188] A. Puig-Kröger,et al. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. , 2001, Blood.
[189] J. Launay,et al. Developmentally regulated serotonin 5-HT2B receptors , 2001, International Journal of Developmental Neuroscience.
[190] T. Pollmächer,et al. Cytokine-associated emotional and cognitive disturbances in humans. , 2001, Archives of general psychiatry.
[191] P. Hirth,et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[192] B. Roth,et al. Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications , 2000, Circulation.
[193] U. Ikeda,et al. Serotonin Increases Interleukin-6 Synthesis in Human Vascular Smooth Muscle Cells , 2000, Circulation.
[194] A. Dierich,et al. Serotonin 2B receptor is required for heart development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[195] E. Bosmans,et al. Effects of Serotonin and Serotonergic Agonists and Antagonists on the Production of Interferon-γ and Interleukin-10 , 2000, Neuropsychopharmacology.
[196] J. Launay,et al. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[197] J. Nordrehaug,et al. Serotonin is associated with coronary artery disease and cardiac events. , 1999, Circulation.
[198] M. Gershon. Review article: roles played by 5‐hydroxytryptamine in the physiology of the bowel , 1999, Alimentary pharmacology & therapeutics.
[199] E. Bosmans,et al. Negative Immunoregulatory Effects of Antidepressants: Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion , 1999, Neuropsychopharmacology.
[200] R. Dantzer,et al. Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice. , 1999, Neuroreport.
[201] K. Lesch,et al. Role of Serotonin in the Immune System and in Neuroimmune Interactions , 1998, Brain, Behavior, and Immunity.
[202] P. Henricks,et al. Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5‐HT receptor antagonists in a mouse model of allergic asthma , 1998, British journal of pharmacology.
[203] W. Edwards,et al. Valvular heart disease associated with fenfluramine-phentermine. , 1997, The New England journal of medicine.
[204] G. Keilhoff,et al. Serotonin Acts as a Radical Scavenger and Is Oxidized to a Dimer During the Respiratory Burst of Activated Microglia , 1997, Journal of neurochemistry.
[205] J. Launay,et al. 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. , 1997, Development.
[206] J Benichou,et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.
[207] J. Depierre,et al. Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells , 1996 .
[208] J. Launay,et al. Ras Involvement in Signal Transduction by the Serotonin 5-HT2B Receptor (*) , 1996, The Journal of Biological Chemistry.
[209] G. Baxter. Novel discriminatory ligands for 5-HT2B receptors , 1995, Behavioural Brain Research.
[210] J M Feldman,et al. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. , 1995, Circulation.
[211] P. Schuff-Werner,et al. Serotonin acts as a radical scavenger and is oxidized to a dimer during the respiratory burst of human mononuclear and polymorphonuclear phagocytes * , 1995, European journal of clinical investigation.
[212] A. Fargin,et al. Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors. , 1995, Cellular immunology.
[213] R. Eglen,et al. The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors , 1995, British journal of pharmacology.
[214] T. Aune,et al. Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. , 1993, Journal of immunology.
[215] K. Nordlind,et al. Inhibiting effects of serotonin and serotonin antagonists on the migration of mononuclear leucocytes. , 1993, Immunopharmacology and immunotoxicology.
[216] K. Hellstrand,et al. Role of Serotonin in the Regulation of Interferon-γ Production by Human Natural Killer Cells , 1993 .
[217] K. Hellstrand,et al. Serotonergic 5‐HT1a Receptors Regulate a Cell Contact‐Mediated Interaction between Natural Killer Cells and Monocytes , 1993, Scandinavian journal of immunology.
[218] W. Stühmer,et al. Cloning and functional characterization of the rat stomach fundus serotonin receptor. , 1992, The EMBO journal.
[219] A. Tajik,et al. Valve Disease Associated with Ergot Alkaloid Use: Echocardiographic and Pathologic Correlations , 1992, Annals of Internal Medicine.
[220] L. Bjursten,et al. Inhibition of leukocyte phagocytosis by serotonin and its possible role in tumor cell destruction. , 1992, Cancer letters.
[221] R. S. Smith. The macrophage theory of depression. , 1991, Medical hypotheses.
[222] K. Hellstrand,et al. Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors. , 1990, Cellular immunology.
[223] E. Arzt,et al. Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway. , 1988, Journal of interferon research.
[224] E. Sternberg,et al. Effect of serotonin (5-HT) and other monoamines on murine macrophages: modulation of interferon-gamma induced phagocytosis. , 1987, Journal of immunology.
[225] S. Timmons,et al. Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of Salmonella minnesota. , 1986, Blood.
[226] E. Sternberg,et al. Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists. , 1986, Journal of immunology.
[227] P. Bradley,et al. Evidence for the existence of 5‐hydroxytryptamine receptors, which are not of the 5‐HT2 type, mediating contraction of rabbit isolated basilar artery , 1986, British Journal of Pharmacology.
[228] C. Benedict,et al. Correlation of Plasma Serotonin Changes with Platelet Aggregation in an in Vivo Dog Model of Spontaneous Occlusive Coronary Thrombus Formation , 1986, Circulation research.
[229] D. Silverman,et al. Muramyl peptides and serotonin interact at specific binding sites on macrophages and enhance superoxide release. , 1985, Biochemical and biophysical research communications.
[230] B. Northover. The effect of histamine and 5-hydroxytryptamine on phagocytosis of staphylococci in vitro by polymorphs and macrophages. , 1961, The Journal of pathology and bacteriology.
[231] D. Mcquarrie,et al. Immediate Effects of Intravenous Endotoxin on Serotonin Concentrations and Blood Platelets , 1960, Circulation research.
[232] J. Vane. The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation. , 1959, British journal of pharmacology and chemotherapy.
[233] M. Cantillon,et al. Pulmonary , gastrointestinal and urogenital pharmacology RP 5063 , a novel , multimodal , serotonin receptor modulator , prevents Sugen 5416-hypoxia – induced pulmonary arterial hypertension in rats , 2017 .
[234] M. Idzko,et al. PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice , 2017 .
[235] M. Cantillon,et al. Pulmonary , gastrointestinal and urogenital pharmacology RP 5063 , a novel , multimodal , serotonin receptor modulator , prevents monocrotaline-induced pulmonary arterial hypertension in rats , 2017 .
[236] M. Kimura,et al. Signal Transduction Mechanism for Serotonin 5-HT2B Receptor-Mediated DNA Synthesis and Proliferation in Primary Cultures of Adult Rat Hepatocytes. , 2016, Biological & pharmaceutical bulletin.
[237] J. Mallet,et al. Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Serotonin Activates Dendritic Cell Function in the Context of Gut Inflammation , 2011 .
[238] M Pytliak,et al. Serotonin receptors - from molecular biology to clinical applications. , 2011, Physiological research.
[239] Taku Sato,et al. Epithelial and Mesenchymal Cell Biology Role of a Serotonin Precursor in Development of Gut Microvilli , 2010 .
[240] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[241] Alberto Mantovani,et al. Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.
[242] C. Nichols,et al. Serotonin receptors. , 2008, Chemical reviews.
[243] J. Launay,et al. Functions of serotonin in hypoxic pulmonary vascular remodeling , 2007, Cell Biochemistry and Biophysics.
[244] M. Young,et al. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. , 1995, Immunology.
[245] M. Costas,et al. Serotonin inhibition of tumor necrosis factor-α synthesis by human monocytes , 1991 .
[246] C. Benedict,et al. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. , 1989, Circulation.
[247] T. Roszman,et al. Specific uptake of serotonin by murine macrophages. , 1988, Life sciences.